CommentHim review: A provocative retelling of the story of Jesus Veteran sci-fi author Geoff Ryman's latest work imagines the son of God as a transgender man. But is this novel really about gender, wonders our new sci-fi columnist Emily H. WilsonCulture
Health2023 saw a cautious hope for Alzheimer's treatment but doubts remain The US approved lecanemab to slow cognitive decline among people with early Alzheimer's, but not everyone is convinced the drug has that big of an impact – not to mention concerns over its safety and practicality News